By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
COVID-19 Rapid Guideline: Managing the Long-term Effects of COVID-19 [NG188]
Overview
This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations about care in all health care settings for adults, children, and young people who have new or ongoing symptoms lasting four weeks or more after onset of acute COVID-19.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: November 11, 2021
Contact: practice@apta.org
Content Type: CPG
Child (6-12), Adolescent (13-18), Young Adult (19-24), Adult (25-44), Middle Aged (45-64), Aged (65+)
You Might Also Like...
Clinical Summary
Long COVIDSep 23, 2022
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. As of July 19, 2022, over 559 million cases of COVID-19 and 6.3
CPG
COVID-19 Rapid Guideline: Managing Symptoms (Including at the End of Life) in the Community [NG191]Mar 23, 2021
Recommendations for managing COVID‑19 symptoms for patients in the community -- babies, children, young people, and adults in all care settings, including